XPENG INC - ADR (XPEV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:XPEV - US98422D1054 - ADR
21.71 USD
+1.69 (+8.44%)
21.73 USD
+0.02 (+0.09%)
XPEV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 35 industry peers in the Automobiles industry. The financial health of XPEV is average, but there are quite some concerns on its profitability. XPEV is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year XPEV has reported negative net income.
In the past year XPEV had a positive cash flow from operations.
In the past 5 years XPEV always reported negative net income.
XPEV had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
XPEV has a better Return On Assets (-4.63%) than 65.71% of its industry peers.
Looking at the Return On Equity, with a value of -14.11%, XPEV is in line with its industry, outperforming 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.63% | ||
| ROE | -14.11% | ||
| ROIC | N/A |
ROA(3y)-10.7%
ROA(5y)-10.09%
ROE(3y)-23.94%
ROE(5y)-19.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
XPEV has a Gross Margin of 16.36%. This is in the better half of the industry: XPEV outperforms 74.29% of its industry peers.
In the last couple of years the Gross Margin of XPEV has grown nicely.
The Profit Margin and Operating Margin are not available for XPEV so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.36% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.06%
GM growth 5YN/A
2. Health
2.1 Basic Checks
XPEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XPEV has been increased compared to 1 year ago.
The number of shares outstanding for XPEV has been increased compared to 5 years ago.
The debt/assets ratio for XPEV is higher compared to a year ago.
2.2 Solvency
XPEV has an Altman-Z score of 1.20. This is a bad value and indicates that XPEV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of XPEV (1.20) is better than 68.57% of its industry peers.
The Debt to FCF ratio of XPEV is 2.65, which is a good value as it means it would take XPEV, 2.65 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of XPEV (2.65) is better than 88.57% of its industry peers.
XPEV has a Debt/Equity ratio of 0.78. This is a neutral value indicating XPEV is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.78, XPEV is in line with its industry, outperforming 48.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 2.65 | ||
| Altman-Z | 1.2 |
ROIC/WACCN/A
WACC8.07%
2.3 Liquidity
A Current Ratio of 1.14 indicates that XPEV should not have too much problems paying its short term obligations.
With a Current ratio value of 1.14, XPEV perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that XPEV should not have too much problems paying its short term obligations.
XPEV's Quick ratio of 1.00 is in line compared to the rest of the industry. XPEV outperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 51.77% over the past year.
The Revenue has grown by 86.64% in the past year. This is a very strong growth!
Measured over the past years, XPEV shows a very strong growth in Revenue. The Revenue has been growing by 77.47% on average per year.
EPS 1Y (TTM)51.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.95%
Revenue 1Y (TTM)86.64%
Revenue growth 3Y24.87%
Revenue growth 5Y77.47%
Sales Q2Q%101.76%
3.2 Future
The Earnings Per Share is expected to grow by 23.29% on average over the next years. This is a very strong growth
Based on estimates for the next years, XPEV will show a very strong growth in Revenue. The Revenue will grow by 30.53% on average per year.
EPS Next Y73.97%
EPS Next 2Y50.36%
EPS Next 3Y36.85%
EPS Next 5Y23.29%
Revenue Next Year90.9%
Revenue Next 2Y62.32%
Revenue Next 3Y45.39%
Revenue Next 5Y30.53%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for XPEV. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 95.08, the valuation of XPEV can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XPEV indicates a somewhat cheap valuation: XPEV is cheaper than 65.71% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.98. XPEV is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 95.08 |
4.2 Price Multiples
88.57% of the companies in the same industry are more expensive than XPEV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.13 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
XPEV's earnings are expected to grow with 36.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.36%
EPS Next 3Y36.85%
5. Dividend
5.1 Amount
XPEV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
21.71
+1.69 (+8.44%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)
Earnings (Next)
Inst Owners12.75%
Inst Owner Change0.06%
Ins Owners0.25%
Ins Owner ChangeN/A
Market Cap20.69B
Revenue(TTM)70.57B
Net Income(TTM)-4.28B
Analysts80
Price Target27.82 (28.14%)
Short Float %9.31%
Short Ratio2.81
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.32%
Min EPS beat(2)34.81%
Max EPS beat(2)47.83%
EPS beat(4)2
Avg EPS beat(4)18.11%
Min EPS beat(4)-8.69%
Max EPS beat(4)47.83%
EPS beat(8)4
Avg EPS beat(8)16.95%
EPS beat(12)4
Avg EPS beat(12)3.67%
EPS beat(16)6
Avg EPS beat(16)-1.04%
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)2.52%
Revenue beat(4)2
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)2.52%
Revenue beat(8)2
Avg Revenue beat(8)-2.74%
Revenue beat(12)2
Avg Revenue beat(12)-5.64%
Revenue beat(16)5
Avg Revenue beat(16)-2.91%
PT rev (1m)0%
PT rev (3m)7.89%
EPS NQ rev (1m)-6.89%
EPS NQ rev (3m)-12.87%
EPS NY rev (1m)-15.02%
EPS NY rev (3m)-10.69%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-1.2%
Revenue NY rev (1m)-0.57%
Revenue NY rev (3m)-2.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 95.08 | ||
| P/S | 2.4 | ||
| P/FCF | 14.13 | ||
| P/OCF | 11.1 | ||
| P/B | 4.76 | ||
| P/tB | 5.56 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.43
EYN/A
EPS(NY)0.23
Fwd EY1.05%
FCF(TTM)1.54
FCFY7.08%
OCF(TTM)1.96
OCFY9.01%
SpS9.06
BVpS4.56
TBVpS3.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.63% | ||
| ROE | -14.11% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.36% | ||
| FCFM | 16.96% |
ROA(3y)-10.7%
ROA(5y)-10.09%
ROE(3y)-23.94%
ROE(5y)-19.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.06%
GM growth 5YN/A
F-Score6
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 2.65 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 129.52% | ||
| Cap/Sales | 4.63% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 1.2 |
F-Score6
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)238.42%
Cap/Depr(5y)371.52%
Cap/Sales(3y)10.3%
Cap/Sales(5y)14.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.95%
EPS Next Y73.97%
EPS Next 2Y50.36%
EPS Next 3Y36.85%
EPS Next 5Y23.29%
Revenue 1Y (TTM)86.64%
Revenue growth 3Y24.87%
Revenue growth 5Y77.47%
Sales Q2Q%101.76%
Revenue Next Year90.9%
Revenue Next 2Y62.32%
Revenue Next 3Y45.39%
Revenue Next 5Y30.53%
EBIT growth 1Y26.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year87.86%
EBIT Next 3Y41.34%
EBIT Next 5Y30.46%
FCF growth 1Y164.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y206.97%
OCF growth 3YN/A
OCF growth 5YN/A
XPENG INC - ADR / XPEV FAQ
Can you provide the ChartMill fundamental rating for XPENG INC - ADR?
ChartMill assigns a fundamental rating of 4 / 10 to XPEV.
What is the valuation status for XPEV stock?
ChartMill assigns a valuation rating of 4 / 10 to XPENG INC - ADR (XPEV). This can be considered as Fairly Valued.
How profitable is XPENG INC - ADR (XPEV) stock?
XPENG INC - ADR (XPEV) has a profitability rating of 2 / 10.